Israeli alpha radiation cancer therapy developer Alpha Tau Medical announced today that it has closed a $29 million financing round led by Shavit Capital and with the participation of OurCrowd, Medison Ventures and private equity investors Sir Ronald Cohen and Alan Patricof.

Read more on Globes here.